Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Toth

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Advances in Health Sciences Education : Theory and Practice|December 8, 2004
Student USMLE step 1 preparation and performanceChi Zhang, Abby Rauchwarger, Cynthia Toth, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Optical Coherence Tomography with Fluorescein Optical Clearing for Transscleral Image GuidanceRobert M Trout, Amit Narawane, Christian Viehland, et al.
The British Journal of Ophthalmology|December 28, 2020
Natural history of central sparing in geographic atrophy secondary to non-exudative age-related macular degenerationLiangbo L Shen, Mengyuan Sun, Aneesha Ahluwalia, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 13, 2005
Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7Hans E Grossniklaus, Päivi H Miskala, W Richard Green, et al.
Ophthalmology|May 25, 2024
P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of PrematurityGil Binenbaum, Andreas Stahl, Aaron S Coyner, et al.
Ophthalmology|March 24, 2020
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results, , Daniel F Martin, et al.
Ophthalmology|May 5, 2012
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Daniel F Martin, Maureen G Maguire, et al.
Ophthalmology|July 11, 2006
Complement factor H increases risk for atrophic age-related macular degenerationEric A Postel, Anita Agarwal, Jennifer Caldwell, et al.
Ophthalmology|October 11, 2012
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationGui-shuang Ying, Jiayan Huang, Maureen G Maguire, et al.
Indian Journal of Ophthalmology|April 24, 2025
Rare pediatric retinal diseases: A reviewAnand Vinekar, Wei-Chi Wu, Birgit Lorenz, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Advances in Health Sciences Education : Theory and Practice|December 8, 2004
Student USMLE step 1 preparation and performanceChi Zhang, Abby Rauchwarger, Cynthia Toth, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Optical Coherence Tomography with Fluorescein Optical Clearing for Transscleral Image GuidanceRobert M Trout, Amit Narawane, Christian Viehland, et al.
The British Journal of Ophthalmology|December 28, 2020
Natural history of central sparing in geographic atrophy secondary to non-exudative age-related macular degenerationLiangbo L Shen, Mengyuan Sun, Aneesha Ahluwalia, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 13, 2005
Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7Hans E Grossniklaus, Päivi H Miskala, W Richard Green, et al.
Ophthalmology|May 25, 2024
P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of PrematurityGil Binenbaum, Andreas Stahl, Aaron S Coyner, et al.
Ophthalmology|March 24, 2020
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results, , Daniel F Martin, et al.
Ophthalmology|May 5, 2012
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Daniel F Martin, Maureen G Maguire, et al.
Ophthalmology|July 11, 2006
Complement factor H increases risk for atrophic age-related macular degenerationEric A Postel, Anita Agarwal, Jennifer Caldwell, et al.
Ophthalmology|October 11, 2012
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationGui-shuang Ying, Jiayan Huang, Maureen G Maguire, et al.
Indian Journal of Ophthalmology|April 24, 2025
Rare pediatric retinal diseases: A reviewAnand Vinekar, Wei-Chi Wu, Birgit Lorenz, et al.
Pageof 2